Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.

Cucci MA, Grattarola M, Dianzani C, Damia G, Ricci F, Roetto A, Trotta F, Barrera G, Pizzimenti S.

Free Radic Biol Med. 2020 Feb 23;150:125-135. doi: 10.1016/j.freeradbiomed.2020.02.021. [Epub ahead of print]

PMID:
32101771
2.

Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver.

Daga M, de Graaf IAM, Argenziano M, Barranco ASM, Loeck M, Al-Adwi Y, Cucci MA, Caldera F, Trotta F, Barrera G, Casini A, Cavalli R, Pizzimenti S.

Toxicol In Vitro. 2020 Feb 19;65:104800. doi: 10.1016/j.tiv.2020.104800. [Epub ahead of print]

PMID:
32084521
3.

Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models.

Argenziano M, Gigliotti CL, Clemente N, Boggio E, Ferrara B, Trotta F, Pizzimenti S, Barrera G, Boldorini R, Bessone F, Dianzani U, Cavalli R, Dianzani C.

Cancers (Basel). 2020 Jan 9;12(1). pii: E162. doi: 10.3390/cancers12010162.

4.

Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models.

Clemente N, Argenziano M, Gigliotti CL, Ferrara B, Boggio E, Chiocchetti A, Caldera F, Trotta F, Benetti E, Annaratone L, Ribero S, Pizzimenti S, Barrera G, Dianzani U, Cavalli R, Dianzani C.

Front Pharmacol. 2019 Jul 12;10:776. doi: 10.3389/fphar.2019.00776. eCollection 2019.

5.

Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells.

Girek M, Kłosiński K, Grobelski B, Pizzimenti S, Cucci MA, Daga M, Barrera G, Pasieka Z, Czarnecka K, Szymański P.

Mol Cell Biochem. 2019 Oct;460(1-2):123-150. doi: 10.1007/s11010-019-03576-x. Epub 2019 Jul 16.

6.

Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells.

Cucci MA, Compagnone A, Daga M, Grattarola M, Ullio C, Roetto A, Palmieri A, Rosa AC, Argenziano M, Cavalli R, Simile MM, Pascale RM, Dianzani C, Barrera G, Pizzimenti S.

Free Radic Biol Med. 2019 Sep;141:205-219. doi: 10.1016/j.freeradbiomed.2019.06.009. Epub 2019 Jun 15.

PMID:
31207288
7.

Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.

Daga M, Pizzimenti S, Dianzani C, Cucci MA, Cavalli R, Grattarola M, Ferrara B, Scariot V, Trotta F, Barrera G.

Phytomedicine. 2019 Mar 15;56:156-164. doi: 10.1016/j.phymed.2018.10.034. Epub 2018 Oct 29.

PMID:
30668336
8.

Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells.

Bessone F, Argenziano M, Grillo G, Ferrara B, Pizzimenti S, Barrera G, Cravotto G, Guiot C, Stura I, Cavalli R, Dianzani C.

Nanotechnology. 2019 May 24;30(21):214004. doi: 10.1088/1361-6528/aaff96. Epub 2019 Jan 17.

PMID:
30654342
9.

Lipid Peroxidation-Derived Aldehydes, 4-Hydroxynonenal and Malondialdehyde in Aging-Related Disorders.

Barrera G, Pizzimenti S, Daga M, Dianzani C, Arcaro A, Cetrangolo GP, Giordano G, Cucci MA, Graf M, Gentile F.

Antioxidants (Basel). 2018 Jul 30;7(8). pii: E102. doi: 10.3390/antiox7080102. Review.

10.

Nasal cytology: Methodology with application to clinical practice and research.

Heffler E, Landi M, Caruso C, Fichera S, Gani F, Guida G, Liuzzo MT, Pistorio MP, Pizzimenti S, Riccio AM, Seccia V, Ferrando M, Malvezzi L, Passalacqua G, Gelardi M.

Clin Exp Allergy. 2018 Sep;48(9):1092-1106. doi: 10.1111/cea.13207. Epub 2018 Jul 9. Review.

PMID:
29904978
11.

Anxiety and Depression Effects During Drug Provocation Test.

Losappio LM, Cappai A, Arcolaci A, Badiu I, Bonadonna P, Boni E, Bussolino C, Caminati M, Galati P, Heffler E, Intravaia R, Mauro M, Massaro I, Romano A, Rumi G, Parolo A, Pizzimenti S, Nichelatti M, Pastorello EA.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1637-1641. doi: 10.1016/j.jaip.2017.12.005. Epub 2018 Jan 12.

PMID:
29339128
12.

Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.

Ciamporcero E, Daga M, Pizzimenti S, Roetto A, Dianzani C, Compagnone A, Palmieri A, Ullio C, Cangemi L, Pili R, Barrera G.

Free Radic Biol Med. 2018 Feb 1;115:447-457. doi: 10.1016/j.freeradbiomed.2017.12.005. Epub 2017 Dec 14.

13.

KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.

Antognelli C, Trapani E, Delle Monache S, Perrelli A, Daga M, Pizzimenti S, Barrera G, Cassoni P, Angelucci A, Trabalzini L, Talesa VN, Goitre L, Retta SF.

Free Radic Biol Med. 2018 Feb 1;115:202-218. doi: 10.1016/j.freeradbiomed.2017.11.014. Epub 2017 Nov 21.

14.

DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity.

Gentile F, Arcaro A, Pizzimenti S, Daga M, Cetrangolo GP, Dianzani C, Lepore A, Graf M, Ames PRJ, Barrera G.

AIMS Genet. 2017 Apr 18;4(2):103-137. doi: 10.3934/genet.2017.2.103. eCollection 2017. Review.

15.

Hypersensitivity reactions due to black henna tattoos and their components: are the clinical pictures related to the immune pathomechanism?

Calogiuri G, Di Leo E, Butani L, Pizzimenti S, Incorvaia C, Macchia L, Nettis E.

Clin Mol Allergy. 2017 Apr 10;15:8. doi: 10.1186/s12948-017-0063-6. eCollection 2017. Review.

16.

Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.

Gigliotti CL, Ferrara B, Occhipinti S, Boggio E, Barrera G, Pizzimenti S, Giovarelli M, Fantozzi R, Chiocchetti A, Argenziano M, Clemente N, Trotta F, Marchiò C, Annaratone L, Boldorini R, Dianzani U, Cavalli R, Dianzani C.

Drug Deliv. 2017 Nov;24(1):670-680. doi: 10.1080/10717544.2017.1303856.

17.

Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells.

Barrera G, Daga M, Ferrara B, Dianzani C, Pizzimenti S, Argenziano M, Cavalli R, Trotta F.

Curr Med Chem. 2017;24(42):4800-4815. doi: 10.2174/0929867323666161205122225. Review.

18.

In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer.

Gigliotti CL, Minelli R, Cavalli R, Occhipinti S, Barrera G, Pizzimenti S, Cappellano G, Boggio E, Conti L, Fantozzi R, Giovarelli M, Trotta F, Dianzani U, Dianzani C.

J Biomed Nanotechnol. 2016 Jan;12(1):114-27.

PMID:
27301177
19.

GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses.

Daga M, Ullio C, Argenziano M, Dianzani C, Cavalli R, Trotta F, Ferretti C, Zara GP, Gigliotti CL, Ciamporcero ES, Pettazzoni P, Corti D, Pizzimenti S, Barrera G.

Free Radic Biol Med. 2016 Aug;97:24-37. doi: 10.1016/j.freeradbiomed.2016.05.009. Epub 2016 May 14.

20.

Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products.

Barrera G, Gentile F, Pizzimenti S, Canuto RA, Daga M, Arcaro A, Cetrangolo GP, Lepore A, Ferretti C, Dianzani C, Muzio G.

Antioxidants (Basel). 2016 Feb 19;5(1). pii: E7. doi: 10.3390/antiox5010007. Review.

21.

Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC).

Heffler E, Landi M, Quadrino S, Incorvaia C, Pizzimenti S, Vernero S, Crimi N, Rolla G, Canonica GW.

Clin Mol Allergy. 2015 Nov 20;13:28. doi: 10.1186/s12948-015-0034-8. eCollection 2015.

22.

Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer.

Lanzardo S, Conti L, Rooke R, Ruiu R, Accart N, Bolli E, Arigoni M, Macagno M, Barrera G, Pizzimenti S, Aurisicchio L, Calogero RA, Cavallo F.

Cancer Res. 2016 Jan 1;76(1):62-72. doi: 10.1158/0008-5472.CAN-15-1208. Epub 2015 Nov 13.

23.

Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models.

Pizzimenti S, Daga M, Ciamporcero E, Toaldo C, Pettazzoni P, Osella-Abate S, Novelli M, Minelli R, Bisazza A, Gamba P, Testa G, Ullio C, Ferruti P, Ranucci E, Bernengo MG, Ferretti C, Dianzani C, Biasi F, Barrera G, Cavalli R.

J Biomed Nanotechnol. 2015 Dec;11(12):2169-85.

PMID:
26510311
24.

Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic.

Heffler E, Pizzimenti S, Guida G, Bucca C, Rolla G.

J Asthma. 2015;52(9):931-4. doi: 10.3109/02770903.2015.1026442. Epub 2015 Aug 18.

25.

YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.

Ciamporcero E, Shen H, Ramakrishnan S, Yu Ku S, Chintala S, Shen L, Adelaiye R, Miles KM, Ullio C, Pizzimenti S, Daga M, Azabdaftari G, Attwood K, Johnson C, Zhang J, Barrera G, Pili R.

Oncogene. 2016 Mar 24;35(12):1541-53. doi: 10.1038/onc.2015.219. Epub 2015 Jun 29.

26.

Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines.

Arcaro A, Daga M, Cetrangolo GP, Ciamporcero ES, Lepore A, Pizzimenti S, Petrella C, Graf M, Uchida K, Mamone G, Ferranti P, Ames PR, Palumbo G, Barrera G, Gentile F.

Oxid Med Cell Longev. 2015;2015:296146. doi: 10.1155/2015/296146. Epub 2015 May 20.

27.

Regulation of B-cell-activating factor expression on the basophil membrane of allergic patients.

Boita M, Heffler E, Pizzimenti S, Raie A, Saraci E, Omedè P, Bussolino C, Bucca C, Rolla G.

Int Arch Allergy Immunol. 2015;166(3):208-12. doi: 10.1159/000381343. Epub 2015 Apr 22.

28.

The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.

Braido F, Melioli G, Candoli P, Cavalot A, Di Gioacchino M, Ferrero V, Incorvaia C, Mereu C, Ridolo E, Rolla G, Rossi O, Savi E, Tubino L, Reggiardo G, Baiardini I, di Marco E, Rinaldi G, Canonica GW; Lantigen Study Group, Accorsi C, Bossilino C, Bonzano L, DiLizia M, Fedrighini B, Garelli V, Gerace V, Maniscalco S, Massaro I, Messi A, Milanese M, Peveri S, Penno A, Pizzimenti S, Pozzo T, Raie A, Regina S, Sclifò F.

Immunol Lett. 2014 Dec;162(2 Pt B):185-93. doi: 10.1016/j.imlet.2014.10.026. Epub 2014 Nov 3.

29.

Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models.

Ciamporcero E, Miles KM, Adelaiye R, Ramakrishnan S, Shen L, Ku S, Pizzimenti S, Sennino B, Barrera G, Pili R.

Mol Cancer Ther. 2015 Jan;14(1):101-10. doi: 10.1158/1535-7163.MCT-14-0094. Epub 2014 Nov 7.

30.

Role of 4-hydroxynonenal-protein adducts in human diseases.

Barrera G, Pizzimenti S, Ciamporcero ES, Daga M, Ullio C, Arcaro A, Cetrangolo GP, Ferretti C, Dianzani C, Lepore A, Gentile F.

Antioxid Redox Signal. 2015 Jun 20;22(18):1681-702. doi: 10.1089/ars.2014.6166. Epub 2015 Jan 20. Review.

31.

Drug delivery nanoparticles in skin cancers.

Dianzani C, Zara GP, Maina G, Pettazzoni P, Pizzimenti S, Rossi F, Gigliotti CL, Ciamporcero ES, Daga M, Barrera G.

Biomed Res Int. 2014;2014:895986. doi: 10.1155/2014/895986. Epub 2014 Jul 2. Review.

32.

Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy.

Pizzimenti S, Heffler E, Gentilcore E, Raie A, Bussolino C, Nebiolo F, Rolla G.

J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):353-4. doi: 10.1016/j.jaip.2014.01.017. Epub 2014 Mar 29. No abstract available.

PMID:
24811032
33.

Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy.

Badiu I, Olivieri E, Montagni M, Guida G, Mietta S, Pizzimenti S, Caminati M, Yacoub MR, Tombetti E, Preziosi D, Quecchia C, Minetti S, Facchetti S, Fassio F, Massaro I, Corradi L, Turi MC, Colagiovanni A, Pascolini L, Rossi FW, Losappio L, Sansone L, Imbesi S, Leto Barone S, Mistrello G, Heffler E.

Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):801-6.

PMID:
24067481
34.

Interaction of aldehydes derived from lipid peroxidation and membrane proteins.

Pizzimenti S, Ciamporcero E, Daga M, Pettazzoni P, Arcaro A, Cetrangolo G, Minelli R, Dianzani C, Lepore A, Gentile F, Barrera G.

Front Physiol. 2013 Sep 4;4:242. doi: 10.3389/fphys.2013.00242. Review.

35.

The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model.

Pizzimenti S, Ciamporcero E, Pettazzoni P, Osella-Abate S, Novelli M, Toaldo C, Husse M, Daga M, Minelli R, Bisazza A, Ferruti P, Ranucci E, Grazia Bernengo M, Dianzani C, Biasi F, Cavalli R, Barrera G.

Free Radic Biol Med. 2013 Dec;65:765-777. doi: 10.1016/j.freeradbiomed.2013.06.035. Epub 2013 Jun 26.

36.

Nasal nitric oxide is a marker of poor asthma control.

Heffler E, Pizzimenti S, Badiu I, Guida G, Ricciardolo FL, Bucca C, Rolla G.

J Breath Res. 2013 Jun;7(2):026009. doi: 10.1088/1752-7155/7/2/026009. Epub 2013 May 10.

37.

Itraconazole as 'bridge therapy' to anti-IgE in a patient with severe asthma with fungal sensitisation.

Pizzimenti S, Bussolino C, Badiu I, Rolla G.

BMJ Case Rep. 2013 Apr 17;2013. pii: bcr2012008462. doi: 10.1136/bcr-2012-008462.

38.

Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells.

Cerbone A, Toaldo C, Minelli R, Ciamporcero E, Pizzimenti S, Pettazzoni P, Roma G, Dianzani MU, Ullio C, Ferretti C, Dianzani C, Barrera G.

PLoS One. 2012;7(6):e40149. doi: 10.1371/journal.pone.0040149. Epub 2012 Jun 28.

39.

AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells.

Cerbone A, Toaldo C, Pizzimenti S, Pettazzoni P, Dianzani C, Minelli R, Ciamporcero E, Roma G, Dianzani MU, Canaparo R, Ferretti C, Barrera G.

PPAR Res. 2012;2012:269751. doi: 10.1155/2012/269751. Epub 2012 Feb 29.

40.

Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells.

Pettazzoni P, Ciamporcero E, Medana C, Pizzimenti S, Dal Bello F, Minero VG, Toaldo C, Minelli R, Uchida K, Dianzani MU, Pili R, Barrera G.

Free Radic Biol Med. 2011 Oct 15;51(8):1610-8. doi: 10.1016/j.freeradbiomed.2011.07.009. Epub 2011 Jul 19.

PMID:
21816220
41.

PPARγ in coronary atherosclerosis: in vivo expression pattern and correlations with hyperlipidemic status and statin treatment.

Pucci A, Formato L, Muscio M, Brscic E, Pizzimenti S, Ferroni F, Ribezzo M, Toaldo C, Pettazzoni P, Ciamporcero E, Barrera G, Rinaldi M, Bergamasco L, Sheiban I, Spinnler MT.

Atherosclerosis. 2011 Oct;218(2):479-85. doi: 10.1016/j.atherosclerosis.2011.06.009. Epub 2011 Jun 13.

42.

Exhaled breath condensate nitrates, but not nitrites or FENO, relate to asthma control.

Malinovschi A, Pizzimenti S, Sciascia S, Heffler E, Badiu I, Rolla G.

Respir Med. 2011 Jul;105(7):1007-13. doi: 10.1016/j.rmed.2010.12.016. Epub 2011 Jan 31.

43.

Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells.

Pettazzoni P, Pizzimenti S, Toaldo C, Sotomayor P, Tagliavacca L, Liu S, Wang D, Minelli R, Ellis L, Atadja P, Ciamporcero E, Dianzani MU, Barrera G, Pili R.

Free Radic Biol Med. 2011 Jan 15;50(2):313-22. doi: 10.1016/j.freeradbiomed.2010.11.011. Epub 2010 Nov 13.

PMID:
21078383
44.

Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients.

Heffler E, Nebiolo F, Asero R, Guida G, Badiu I, Pizzimenti S, Marchese C, Amato S, Mistrello G, Canaletti F, Rolla G.

Allergy. 2011 Feb;66(2):264-70. doi: 10.1111/j.1398-9995.2010.02469.x. Epub 2010 Aug 30.

PMID:
20804471
45.

The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer.

Pizzimenti S, Toaldo C, Pettazzoni P, Dianzani MU, Barrera G.

Cancers (Basel). 2010 Mar 30;2(2):338-63. doi: 10.3390/cancers2020338.

46.

Effect of arterial hypertension on chronic urticaria duration.

Nebiolo F, Bergia R, Bommarito L, Bugiani M, Heffler E, Carosso A, Castiglioni G, Guida G, Badiu I, Pizzimenti S, Mietta S, Ferrero N, Rolla G.

Ann Allergy Asthma Immunol. 2009 Nov;103(5):407-10. doi: 10.1016/S1081-1206(10)60360-2.

PMID:
19927539
47.

PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells.

Toaldo C, Pizzimenti S, Cerbone A, Pettazzoni P, Menegatti E, Daniela B, Minelli R, Giglioni B, Dianzani MU, Ferretti C, Barrera G.

J Cell Mol Med. 2010 Jun;14(6A):1347-57. doi: 10.1111/j.1582-4934.2009.00966.x. Epub 2009 Nov 13.

48.

Determinants of exhaled nitric oxide in chronic rhinosinusitis.

Guida G, Rolla G, Badiu I, Marsico P, Pizzimenti S, Bommarito L, De Stefani A, Usai A, Bugiani M, Malinovschi A, Bucca C, Heffler E.

Chest. 2010 Mar;137(3):658-64. doi: 10.1378/chest.09-0667. Epub 2009 Oct 16.

PMID:
19837820
49.

4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity.

Pizzimenti S, Menegatti E, Berardi D, Toaldo C, Pettazzoni P, Minelli R, Giglioni B, Cerbone A, Dianzani MU, Ferretti C, Barrera G.

J Nutr Biochem. 2010 Sep;21(9):818-26. doi: 10.1016/j.jnutbio.2009.06.005. Epub 2009 Sep 3.

PMID:
19733043
50.

Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity.

Gentile F, Pizzimenti S, Arcaro A, Pettazzoni P, Minelli R, D'Angelo D, Mamone G, Ferranti P, Toaldo C, Cetrangolo G, Formisano S, Dianzani MU, Uchida K, Dianzani C, Barrera G.

Biochem J. 2009 Aug 13;422(2):285-94. doi: 10.1042/BJ20090564.

PMID:
19508232

Supplemental Content

Loading ...
Support Center